FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT) on behalf of Fulgent stockholders.
- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT) on behalf of Fulgent stockholders.
- Our investigation concerns whether Fulgent has violated the federal securities laws and/or engaged in other unlawful business practices.
- Fulgent released its financial results for the second quarter of 2022 on August 4, 2022.
- The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.